Results 161 to 170 of about 4,574,160 (318)

Unlocking the potential of light-intensity physical activity for public health: a call to action for research. [PDF]

Br J Sports Med
Prince SA, Chaput JP, Colley RC, Dempsey PC, Ekelund U, Janssen I, Lang JJ, Stamatakis E, Tarp J, Tremblay MS, Betancourt MT, Butler GP, Roberts KC.   +12 more
europepmc   +1 more source

Minutes: Benefits Advisory Committee: March 28, 2013

, 2013
University of Minnesota: Benefits Advisory Committee. (2013). Minutes: Benefits Advisory Committee: March 28, 2013.
University of Minnesota: Benefits Advisory Committee
core  

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

FEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin, Naghme Radmannia, David N. Huynh, Liliane Ménard, Caroline Daneault, Maïté Veilleux, Ahsanullah Ahsanullah, André C. Carpentier, William D. Lubell, Matthieu Ruiz, Huy Ong, Sylvie Marleau, Simon‐Pierre Gravel   +12 more
wiley   +1 more source

89 Stroke Prevention in Atrial Fibrillation and Flutter - Targeting the Untreated Patients In Veterans Health Administration with a Pharmacists-Led, Multi-Center Electronic Health Record Intervention (SPAFF-TNT)

Research and Practice in Thrombosis and Haemostasis
Arthur Allen, Jeffery Kibert, Geoffrey Barnes, Michael Dyal, Paul Varosy, David Parra   +5 more
doaj   +1 more source

Efficient use of prohexadione-Ca in pome fruits

European Journal of Horticultural Science, 2003
W. Rademacher, R. Kober
doaj   +1 more source

Bundling medical and pharmacy benefits: Impact on medical costs. [PDF]

J Manag Care Spec Pharm
Wilkinson ES, David G, Kumar R, Saynisch PA, Smith-McLallen A.   +4 more
europepmc   +1 more source

Minutes: Benefits Advisory Committee: February 19, 2015

, 2015
University of Minnesota. Benefits Advisory Committee. (2015). Minutes: Benefits Advisory Committee: February 19, 2015.
University of Minnesota. Benefits Advisory Committee
core  

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Minutes: Benefits Advisory Committee: December 11, 2025

University of Minnesota. Benefits Advisory Committee. (2025). Minutes: Benefits Advisory Committee: December 11, 2025.
University of Minnesota. Benefits Advisory Committee
core  

Minutes: Benefits Advisory Committee: May 26, 2016

, 2016
University of Minnesota. Benefits Advisory Committee. (2016). Minutes: Benefits Advisory Committee: May 26, 2016.
University of Minnesota. Benefits Advisory Committee
core